These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 25555857)

  • 1. Letter to the editor, in response to the letter entitled: Mean platelet volume in retinal vein occlusions?
    Örnek K
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3733. PubMed ID: 25555857
    [No Abstract]   [Full Text] [Related]  

  • 2. Mean platelet volume in retinal vein occlusions.
    Şahin A
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3734. PubMed ID: 25555858
    [No Abstract]   [Full Text] [Related]  

  • 3. Mean platelet volume in retinal vein occlusion.
    Yolcu Ü; Taş A; Ilhan A; Gündoğan FC
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):521. PubMed ID: 25753862
    [No Abstract]   [Full Text] [Related]  

  • 4. Mean platelet volume in retinal vein occlusion.
    Ornek N; Ogurel T; Ornek K; Onaran Z
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2778-82. PubMed ID: 25339469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous central retinal vein and retinal artery branch occlusions in two patients with homocystinaemia.
    Ozdek S; Yülek F; Gürelik G; Aydin B; Hasanreisoğlu B
    Eye (Lond); 2004 Sep; 18(9):942-5. PubMed ID: 15002016
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma total homocysteine and retinal vascular disease.
    Martin SC; Rauz S; Marr JE; Martin N; Jones AF; Dodson PM
    Eye (Lond); 2000 Aug; 14 ( Pt 4)():590-3. PubMed ID: 11040905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombin-antithrombin III complex. Cause of venous vascular occlusion of the retina].
    Krüger K; Anger V; Haas D
    Ophthalmologe; 1992 Feb; 89(1):67-70. PubMed ID: 1581696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
    Lip PL; Blann AD; Jones AF; Lip GY
    Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma endothelial-1 concentrations in patients with retinal vein occlusions.
    Hólló G
    Br J Ophthalmol; 1999 Jan; 83(1):127-8. PubMed ID: 10209457
    [No Abstract]   [Full Text] [Related]  

  • 10. Retinal vein occlusion disease and platelet activation: will antiplatelet therapy be a promising therapeutic strategy for patients with retinal vein occlusion disease in the future?
    Fateh-Moghadam S; Gawaz M
    Thromb Haemost; 2007 Feb; 97(2):169-70. PubMed ID: 17264941
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemostasis and central retinal vein occlusion].
    Pelosse B; Massin P; Bouzas E
    Ophtalmologie; 1988 Oct; 2(4):335-6. PubMed ID: 3247202
    [No Abstract]   [Full Text] [Related]  

  • 12. [Increase of erythrocyte aggregation in retinal vein occlusion].
    Glacet-Bernard A; Chabanel A; Coscas G; Lelong F; Samama M
    J Fr Ophtalmol; 1990; 13(10):500-5. PubMed ID: 2081840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered platelet morphological parameters in patients with retinal vein occlusion.
    Yilmaz T; Yilmaz A
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1934-9. PubMed ID: 27249589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to the letter to the editor: Venous oxygen saturation is reduced and variable in central retinal vein occlusion.
    Eliasdottir TS; Bragason D; Hardarson SH; Kristjansdottir G; Stefánsson E
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1405. PubMed ID: 25563728
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibitors of blood coagulation in vascular occlusion of the retina and optic nerve].
    Krüger K; Witt I
    Fortschr Ophthalmol; 1990; 87(2):178-81. PubMed ID: 2141589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new insight into retinal vein occlusion pathogenesis.
    Karska-Basta I; Kubicka-Trzaska A; Pogrzebielski A; Romanowska-Dixon B
    Klin Oczna; 2013; 115(4):269-74. PubMed ID: 24908915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in plasma TxB2 and 6-keto-PGF1 alpha in patients with retinal vein occlusion].
    Wu YZ
    Zhonghua Yan Ke Za Zhi; 1993 Nov; 29(6):359-61. PubMed ID: 8020381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ultra-low-molecular-weight heparin, fondaparinux, to treat retinal vein occlusion.
    Steigerwalt RD; Pascarella A; De Angelis M; Ciucci F; Gaudenzi F
    Drug Discov Ther; 2016; 10(3):167-71. PubMed ID: 27301712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial occlusion of central veins associated with type II familial hyperlipoproteinemia].
    Castella A; Othenin-Girard P
    Klin Monbl Augenheilkd; 1992 May; 200(5):346-8. PubMed ID: 1614098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal and orbital venous occlusions treated with enoxaparin.
    Steigerwalt RD; Cesarone MR; Belcaro G; Quercioli P; Lofoco G; Ciucci F; Pascarella A; Angelis MD; Rapagnetta L; Nebbioso M
    J Ocul Pharmacol Ther; 2008 Aug; 24(4):421-6. PubMed ID: 18665814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.